78 related articles for article (PubMed ID: 7478121)
1. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
Kamper AL; Strandgaard S; Leyssac PP
Nephrol Dial Transplant; 1995; 10(7):1182-8. PubMed ID: 7478121
[TBL] [Abstract][Full Text] [Related]
2. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
3. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Matalone M; Pisoni R; Gaspari F; Remuzzi G
Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
[TBL] [Abstract][Full Text] [Related]
4. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
5. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
Kamper AL; Strandgaard S; Leyssac PP
Ugeskr Laeger; 1993 Aug; 155(31):2406-9. PubMed ID: 8346593
[TBL] [Abstract][Full Text] [Related]
6. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
[TBL] [Abstract][Full Text] [Related]
7. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz HE; Wiegmann TB; Cnaan A; Shahinfar S; Sica DA; Broadstone V; Schwartz SL; Mengel MC; Segal R; Versaggi JA
Kidney Int Suppl; 1994 Feb; 45():S150-5. PubMed ID: 8158885
[TBL] [Abstract][Full Text] [Related]
8. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
9. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria.
de Mello VD; Zelmanovitz T; Azevedo MJ; de Paula TP; Gross JL
J Ren Nutr; 2008 Sep; 18(5):440-7. PubMed ID: 18721739
[TBL] [Abstract][Full Text] [Related]
11. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
13. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
15. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
Kamper AL; Holstein-Rathlou NH; Leyssac PP; Strandgaard S
Am J Kidney Dis; 1996 Dec; 28(6):822-31. PubMed ID: 8957033
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitor and chronic renal failure.
Sitprija V; Lumlertgul D
J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635
[TBL] [Abstract][Full Text] [Related]
18. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
Elung-Jensen T; Heisterberg J; Sonne J; Strandgaard S; Kamper AL
Eur J Clin Pharmacol; 2005 Apr; 61(2):87-96. PubMed ID: 15761754
[TBL] [Abstract][Full Text] [Related]
19. Enalapril in the treatment of hypertension associated with renal failure: results from a multicenter study.
Mioli V; Boggi R; Greco A; Capponi E; Trivelli G; Cecchini F; Acciarri PM; Concetti M; Panichi N; Radicioni R
Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):127-34. PubMed ID: 2080310
[TBL] [Abstract][Full Text] [Related]
20. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.
Kamper AL; Nielsen OJ
Scand J Clin Lab Invest; 1990 Oct; 50(6):611-8. PubMed ID: 2247767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]